PRNewsWire
27 Dec 2025, 20:56 UTC · 37w ago
Verdict
Headline leans bearish. We score INSP −1.00 across three claims.
Score confirms the headline.
Leans bearish
From its wording — no explicit rating
−1.00strongly bearish
What the story claims
3 claims · scored −1 bearish … +1 bullish
Inspire Medical Systems slashed its 2025 EPS guidance by over 80% following a flawed Inspire V product launch.
So whatA massive reduction in earnings guidance is a primary driver of stock devaluation and indicates severe fundamental business deterioration.
More negative than 99% of claims this week
A securities class action lawsuit alleges that Inspire Medical concealed Medicare billing software failures and an inventory glut of the older Inspire IV device.
Continue reading
5 related stories
More negative than 96% of ticker scores this week
Scored by the NIS engine · methodology.
Top 2 movers · tap to explore
More negative than 92% of claims this week
Operational failures including incomplete training and onboarding at many centers stalled the adoption of the Inspire V device.
More negative than 81% of claims this week
Which stocks this story touches
More negative than 96% of ticker scores this week
The company is facing a securities fraud class action lawsuit following a significant stock drop and allegations of concealing operational failures.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Newsfile Corp
20h ago
−19.4%
Price agrees with the score
$76.96 vs $95.47 close before publication (Dec 26) · not market-adjusted
INSP chart →
